Cure8 news brief
Early intestinal ultrasound may predict one-year endoscopic remission in Crohn's disease, offering a noninvasive tool to guide treatment decisions and possibly reduce the need for some colonoscopies.
Clinicians managing Crohn's disease, patients starting or on biologic (anti‑TNF) therapy, researchers studying monitoring strategies, and IBD care teams interested in noninvasive monitoring.
The study enrolled adults starting anti–TNF therapy and performed IUS, biomarkers, and endoscopic or imaging assessments over one year. About 40% achieved endoscopic remission and 42% achieved IUS remission at week 54. Lower bowel wall thickness and IBUS-SAS scores were associated with endoscopic remission.
The authors propose using week-14 IUS thresholds to guide treatment adjustments and reduce routine ileocolonoscopies. The findings are encouraging for using IUS in tight monitoring, but the study included 63 patients with 57 completing 54 weeks and was limited to anti–TNF starters.
Larger and more diverse cohorts are needed to validate the IBUS-SAS cut points across different drug classes and practice settings.
This was a prospective multicenter study of adults initiating anti‑TNF therapy with 57 patients reaching 54‑week follow-up. Results are promising but need validation in larger, more diverse cohorts and across other medication classes before changing standard monitoring protocols.
Review the original publication for the complete reporting, methods, and context.
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
A reliable, accurate intestinal ultrasound could make routine monitoring easier, faster, and less costly than repeated MRI for people with Crohn’s disease. The study shows strong agreement between ultrasound scores and...
This study suggests using both faecal calprotectin and intestinal ultrasound together can better identify patients who reach deeper, transmural healing — and those patients had lower risk of bowel-damage progression....
This study suggests intestinal ultrasound findings early after diagnosis — especially achieving “transmural remission” within 3 months — may predict better 1-year outcomes (sustained steroid-free remission and less need...
